FDA Inspection
Michael T. Collins, M.D.Michael T. Collins, M.D. – FDA Inspection, Mar 11, 2010
Record Details
This FDA Inspection record concerns Michael T. Collins, M.D., with an inspection on March 11, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michael T. Collins, M.D.
- Inspection Date
- March 11, 2010
- Product Type
- Drugs
View Company Profile
ID · be41bbca-ef92-4819-80f6-2fc34d863024
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 652311
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Changes in research
- 21 CFR 50.25(a)(1)Procedures, identification of those which were experimental
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael T. Collins, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 2, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael T. Collins, M.D.
- FDA Inspection 964409 - 2016-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.